Nanolive is delighted to invite you for an upcoming exclusive in-person event at UC San Francisco, on November 17th, 2023, from 11.00am to 1.00pm. Nanolive delivers breakthrough label-free live cell and phenotypic solutions that combine screening, imaging and analysis...
Presentation Nanolive is delighted to invite you to attend our upcoming presentation at the ELRIG Drug Discovery 2023 Conference in Liverpool on October 18, 2023, from 16:15 to 16:30 in Auditorium 1. During our talk, “A powerful solution for high content label-free...
Label-free live cell and phenotypic analysis solutions Nanolive is delighted to invite you to the Stanford Seminar with Nanolive at Stanford University, on October 30th, 2023, from 1:30pm to 3:00pm. Nanolive delivers breakthrough label-free live cell and phenotypic...
Congratulations to the Conrad lab for their latest Nature paper ‘Phase separation of FSP1 promotes ferroptosis’! This beautiful capture published as part of the paper provides new information about the events leading up to ferroptotic cell death. Using...
We are thrilled to announce a groundbreaking scientific study authored by Mathieu Frechin and Daniel Olive, in collaboration with Aix Marseille Université, ImCheck therapeutics, and Nanolive. Their remarkable research on Vγ9Vδ2 T cells has opened up new possibilities...
